InsideOutBio
Corporate brand
UnclaimedInsideOutBio is a Charlestown-based immunology company that reprograms cancer cells to make them immunogenic and licenses its innate immunity and vaccine development intellectual property.
Last updated September 28, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
InsideOutBio is a United States-based immunology company headquartered in Charlestown. According to its official website, the company focuses on reprogramming cancer cells to make them immunogenic, using a novel immune therapy approach intended to build long-lasting immunity. Its stated mission is "Fighting cancer from the inside out." The company describes itself as holding wholly owned intellectual property in the immunology space that is available for license. Its focus is on innate immunity and vaccine development without regard to therapeutic modality. InsideOutBio provides design services based on its portfolio for applications in research, development, clinical, diagnostic and testing services in the fields of cancer, central nervous system disorders, neurodegenerative diseases and inflammatory conditions. It invites potential partners to contact it through a web form to begin the process of providing prototypes and solutions, noting that it programs solutions and has trusted vendors to implement them. InsideOutBio operates as a corporate brand in the biotechnology and immune therapeutics sector. Its business model combines internal immune therapy development with licensing and design services for external partners. The company is associated with Charlestown in the United States, as recorded in Wikidata. No public information is available in the supplied evidence regarding its founding year, founders, ownership structure, or executive leadership.
History
InsideOutBio is a United States-based immunology company headquartered in Charlestown. The company's official website states its mission as "Fighting cancer from the inside out," reflecting its approach of reprogramming cancer cells to make them immunogenic using a novel immune therapy to build long-lasting immunity. The company holds wholly owned intellectual property in the immunology space that is available for license. Its focus is on innate immunity and vaccine development without regard to therapeutic modality. InsideOutBio provides design services based on its portfolio for applications in research, development, clinical, diagnostic and testing services in the fields of cancer, central nervous system disorders, neurodegenerative diseases and inflammatory conditions. It works with trusted vendors to implement solutions. No specific historical milestones, founding date, or leadership details are available in the supplied evidence.
Products and positioning
Immunology company focused on innate immunity and vaccine development, offering IP licensing and design services for cancer, CNS, neurodegenerative, and inflammatory conditions.
Cancer cell reprogramming immune therapy
A novel immune therapy that reprograms cancer cells to make them immunogenic, aiming to build long-lasting immunity.
Intellectual property licensing
Wholly owned intellectual property in the immunology space available for license.
Design services
Design services based on the company's portfolio for applications in research, development, clinical, diagnostic and testing services in cancer, CNS disorders, neurodegenerative diseases and inflammatory conditions.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/insideoutbio-united-states · Editorial policy · How profiles are compiled